Who Paid My Doc
Nexplanon
Drug Womens Health
NDC 0052-4330-01
General payments
$4,258,627
Research payments
$3,662,827
Through program year 2021, $4,258,627 in general payments and $3,662,827 in research payments were reported against Nexplanon (Womens Health).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | General | $1,145,844 | 6,281 |
| 2021 | Research | $2,596,841 | 24 |
| 2020 | General | $917,737 | 6,508 |
| 2020 | Research | $460,580 | 8 |
| 2019 | General | $2,195,046 | 17,600 |
| 2019 | Research | $605,407 | 3 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.
The top 5 of 66 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.
The top 5 of 51 states; each share is of general payments naming this product in 2021 where a state was reported.
Records
30,389 general · 35 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.